RBC Capital Reiterates Outperform Rating on Ovintiv, Sets $90 Target
RBC Capital reiterated its Outperform rating on Ovintiv and maintained a $90 price target. The target implies 35.0% upside from the Oct. 13 close of $66.66.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.